REL:LSERELX PLC Analysis
Data as of 2026-05-24 - not real-time
£2,447.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
RELX trades at 2,447 p, sitting below its 20‑day (2,540.65 p) and 50‑day (2,549 p) simple moving averages, with a bearish MACD histogram (‑7.37) and a neutral‑to‑slightly‑oversold RSI of 42.6, signalling short‑term downside pressure. The stock’s 30‑day volatility is elevated at ~33 % while its beta is only 0.11, indicating market‑wide moves have limited impact but price swings are pronounced. A discounted cash‑flow model values the company at roughly 1,270 p, implying the market price is more than double intrinsic value, and the upside/downside metric flags a substantial downside potential. Despite this, RELX’s fundamentals remain robust: gross margin of 66 %, operating margin of 31 %, ROE of 70 %, and a sustainable dividend yield of 2.76 % with a payout ratio around 57 %.
The recent launch of a £350 million tranche in its 2026 share‑buyback programme adds a modest catalyst, and analysts collectively rate the stock as a “strong buy” with a median target near £3,450. However, the stark valuation gap and bearish technical setup suggest caution. Over the medium to long term, the company’s diversified, high‑margin business model and dividend stability support a hold stance, while short‑term positioning may tilt toward selling into the current over‑extension.
The recent launch of a £350 million tranche in its 2026 share‑buyback programme adds a modest catalyst, and analysts collectively rate the stock as a “strong buy” with a median target near £3,450. However, the stark valuation gap and bearish technical setup suggest caution. Over the medium to long term, the company’s diversified, high‑margin business model and dividend stability support a hold stance, while short‑term positioning may tilt toward selling into the current over‑extension.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below 20‑ and 50‑day SMAs
- Bearish MACD signal
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong cash flow and high ROE
- Sustainable dividend yield
- Share‑buyback programme adding modest support
Long Term
> 3 yearsNeutral
Model confidence: 8/10
Key Factors
- Diversified, high‑margin business segments
- Low beta indicating defensive characteristics
- Consistent dividend payments and low debt‑to‑equity pressure
Key Metrics & Analysis
Financial Health
Revenue Growth1.20%
Profit Margin21.53%
P/E Ratio21.8
ROE70.51%
ROA12.49%
Debt/Equity304.06
P/B Ratio18.8
Op. Cash Flow£2.8B
Free Cash Flow£2.2B
Industry P/E29.7
Technical Analysis
TrendBearish
RSI42.6
Support£2,297.00
Resistance£2,765.00
MA 20£2,540.65
MA 50£2,549.00
MA 200£2,958.74
MACDBearish
VolumeStable
Fear & Greed Index91.61
Valuation
Fair Value£1,269.54
Target Price£3,618.17
Upside/Downside47.86%
GradeOvervalued
TypeValue
Dividend Yield2.76%
Risk Assessment
Beta0.11
Volatility32.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.